| When: Thursday, 11/4/2021, 5:00 pm - 6:30 pm |
| Credits: 1.5 CME_Physicians Credits |
| Credits: 1.5 CME_OtherProfessions Credits |
|
Description: Hyper-palatable foods (HPF) are ubiquitous in the food environment and are frequently described as contributing to the obesity epidemic. Until recently, there has not been a clear definition of what these foods may be, how these foods may drive overeating, and how policy can assist with reducing the negative health impact these foods may produce. This symposium will present research on recently developed definitions for HPF and how HPFs are related to energy intake and weight regulation; how HPFs fit into the construct of addictive-like eating behavior, which evidence supports as being a unique construct that is consistent with meeting criteria for substance use disorder diagnoses; and policy options, such as taxes, incentives, and product reformulation, that may assist with reducing population intake of HPFs.
This session was jointly produced by The Obesity Society (TOS) and Weight Management Dietetic Practice Group of the Academy of Nutrition and Dietetics (WMDPG).
|
| Delivery Mechanism: Broadcast |
| Keyword: Behavioral Psychology: Eating Behaviors; Behavioral Psychology: Reward/Addiction; Energy Balance: Energy Intake |
Track: Sub-track: Nutrition; Track 3: Interventional and Clinical Studies
|
|
Speakers:
 | Maria E. Morgan-Bathke, MBA, PhD, RD, CD, FAND | Session Chair | |  | Tera L. Fazzino, PhD | What Are HPFs? | 5:00 pm - 5:20 pm |  | Tracy Burrows | Addictive-like Eating Behavior: How It Is Related to Overeating and the Role of HPFs | 5:20 pm - 5:40 pm |  | Jessi E. Silverman, MSPH, RD | The Role of Food Policy in HPFs | 5:40 pm - 6:00 pm | | Maria E. Morgan-Bathke, MBA, PhD, RD, CD, FAND | Moderate Panel Q&A | 6:00 pm - 6:30 pm | | Tera L. Fazzino, PhD | Panel Q&A | 6:00 pm - 6:30 pm | | Tracy Burrows | Panel Q&A | 6:00 pm - 6:30 pm | | Jessi E. Silverman, MSPH, RD | Panel Q&A | 6:00 pm - 6:30 pm |
|
|
| Learning Objectives: |
| 1. Apply the latest recommendations for evaluation and treatment; tailor intervention strategies based on patient characteristics such as age or metabolic or behavioral phenotype; understand the differences between weight loss and weight loss maintenance. |
| 2. Understand the evidence-based science regarding neuroendocrine, environmental, endocrine, microbiota and/or cognitive behavioral mechanisms regulating energy balance and body weight. Apply that knowledge to develop and implement treatment options for adults and pediatric patients with overweight, obesity or obesity-related co-morbidities. |
| 5. Apply new knowledge related to dietary intervention and physical activity from the perspectives of Metabolism and Integrative Physiology, Neuroscience, Intervention and Clinical Studies, Population Health, Clinical/Professional Practice, and Policy/Public Health. |
|
|